Alpha Tau Medical (DRTS) Income from Continuing Operations (2021 - 2026)

Alpha Tau Medical (DRTS) has 6 years of Income from Continuing Operations data on file, last reported at 22950000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations rose 170.22% year-over-year to 22950000.0; the trailing twelve-month figure through Mar 2026 stood at 56842000.0 (up 76.24% YoY), and the FY2025 full-year result was 42385000.0, up 33.55% from the prior year.
• Income from Continuing Operations advanced to 22950000.0 in Q1 2026, from 12206000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 25740000.0 in Q1 2022 to a low of 1987000.0 in Q2 2022.
• A 5-year average of 9407058.82 and a median of 8145000.0 in 2023 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations tumbled 71.42% in 2022 and jumped 334.88% in 2023, its largest moves.
• Tracing DRTS's Income from Continuing Operations over 5 years: stood at 3390000.0 in 2022, then soared by 116.78% to 7349000.0 in 2023, then increased by 28.89% to 9472000.0 in 2024, then increased by 28.86% to 12206000.0 in 2025, then soared by 88.02% to 22950000.0 in 2026.
• Business Quant data shows DRTS's Income from Continuing Operations at 22950000.0 in Q1 2026, 12206000.0 in Q4 2025, and 11702000.0 in Q3 2025.